Literature DB >> 22510256

Resting state FDG-PET functional connectivity as an early biomarker of Alzheimer's disease using conjoint univariate and independent component analyses.

Paule-Joanne Toussaint1, Vincent Perlbarg, Pierre Bellec, Serge Desarnaud, Lucette Lacomblez, Julien Doyon, Marie-Odile Habert, Habib Benali.   

Abstract

Imaging cerebral glucose metabolism with positron emission tomography (PET) in Alzheimer's disease (AD) has allowed for improved characterisation of this pathology. Such patterns are typically analysed using either univariate or multivariate statistical techniques. In this work we combined voxel-based group analysis and independent component analysis to extract differential characteristic patterns from PET data of glucose metabolism in a large cohort of normal elderly controls and patients with AD. The patterns were used in conjunction with a support vector machine to discriminate between subjects with mild cognitive impairment (MCI) at risk or not of converting to AD. The method was applied to baseline fluoro-deoxyglucose (FDG)-PET images of subjects from the ADNI database. Our approach achieved improved early detection and differentiation of typical versus pathological metabolic patterns in the MCI population, reaching 80% accuracy (85% sensitivity and 75% specificity) when using selected regions. The method has the potential to assist in the advance diagnosis of Alzheimer's disease, and to identify early in the development of the disease those individuals at high risk of rapid cognitive decline who could be candidates for new therapeutic approaches.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22510256     DOI: 10.1016/j.neuroimage.2012.03.091

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  45 in total

Review 1.  A review of feature reduction techniques in neuroimaging.

Authors:  Benson Mwangi; Tian Siva Tian; Jair C Soares
Journal:  Neuroinformatics       Date:  2014-04

Review 2.  Clinical utility of FDG-PET for the clinical diagnosis in MCI.

Authors:  Javier Arbizu; Cristina Festari; Daniele Altomare; Zuzana Walker; Femke Bouwman; Jasmine Rivolta; Stefania Orini; Henryk Barthel; Federica Agosta; Alexander Drzezga; Peter Nestor; Marina Boccardi; Giovanni Battista Frisoni; Flavio Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-27       Impact factor: 9.236

Review 3.  A Cochrane review on brain [¹⁸F]FDG PET in dementia: limitations and future perspectives.

Authors:  Silvia Morbelli; Valentina Garibotto; Elsmarieke Van De Giessen; Javier Arbizu; Gaël Chételat; Alexander Drezgza; Swen Hesse; Adriaan A Lammertsma; Ian Law; Sabina Pappata'; Pierre Payoux; Marco Pagani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09       Impact factor: 9.236

4.  Transmodal Learning of Functional Networks for Alzheimer's Disease Prediction.

Authors:  Mehdi Rahim; Bertrand Thirion; Claude Comtat; Gaël Varoquaux
Journal:  IEEE J Sel Top Signal Process       Date:  2016-08-15       Impact factor: 6.856

Review 5.  Biomarkers, designs, and interpretations of resting-state fMRI in translational pharmacological research: A review of state-of-the-Art, challenges, and opportunities for studying brain chemistry.

Authors:  Najmeh Khalili-Mahani; Serge A R B Rombouts; Matthias J P van Osch; Eugene P Duff; Felix Carbonell; Lisa D Nickerson; Lino Becerra; Albert Dahan; Alan C Evans; Jean-Paul Soucy; Richard Wise; Alex P Zijdenbos; Joop M van Gerven
Journal:  Hum Brain Mapp       Date:  2017-02-01       Impact factor: 5.038

6.  Modulation of glucose metabolism and metabolic connectivity by β-amyloid.

Authors:  Felix Carbonell; Alex P Zijdenbos; Donald G McLaren; Yasser Iturria-Medina; Barry J Bedell
Journal:  J Cereb Blood Flow Metab       Date:  2016-06-14       Impact factor: 6.200

7.  Integrated multimodal network approach to PET and MRI based on multidimensional persistent homology.

Authors:  Hyekyoung Lee; Hyejin Kang; Moo K Chung; Seonhee Lim; Bung-Nyun Kim; Dong Soo Lee
Journal:  Hum Brain Mapp       Date:  2016-11-17       Impact factor: 5.038

8.  Metabolic connectomics targeting brain pathology in dementia with Lewy bodies.

Authors:  Silvia P Caminiti; Marco Tettamanti; Arianna Sala; Luca Presotto; Sandro Iannaccone; Stefano F Cappa; Giuseppe Magnani; Daniela Perani
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 9.  2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Jesse Cedarbaum; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Johan Luthman; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie Shaw; Li Shen; Adam Schwarz; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2015-06       Impact factor: 21.566

10.  Brain PET amyloid and neurodegeneration biomarkers in the context of the 2018 NIA-AA research framework: an individual approach exploring clinical-biomarker mismatches and sociodemographic parameters.

Authors:  Artur Martins Coutinho; Geraldo F Busatto; Fábio Henrique de Gobbi Porto; Daniele de Paula Faria; Carla Rachel Ono; Alexandre Teles Garcez; Paula Squarzoni; Fábio Luiz de Souza Duran; Maira Okada de Oliveira; Eduardo Sturzeneker Tres; Sonia Maria Dozzi Brucki; Orestes Vicente Forlenza; Ricardo Nitrini; Carlos Alberto Buchpiguel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-02-13       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.